Login

Join for Free!
117148 members
table of contents table of contents

“Survival of the fittest” holds good for men and animals as also …


Biology Articles » Microbiology » The challenge of antibiotic resistance: Need to contemplate » References

References
- The challenge of antibiotic resistance: Need to contemplate

1. Cohen ML. Changing patterns of infectious disease. Nature 2000; 406 : 762-7.

2. Neu H C. The crisis in antibiotic resistance. Science 1992; 257 : 1064-73.

3. Kunin CM. Resistance to antimicrobial drugs - a world wide calamity. Ann Intern Med 1993; 118 : 557-61.

4. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9 : 1065-78.

5. Weinstein RA. Controlling antimicrobial resistance in hospitals : Infection control and use of antibiotics. Emerg Infect Dis 2001; 7 : 188-92.

6. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial - resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA.1996; 275 : 234-40.

7. Houten MA, Kumpen JLL. Antimicrobial practice and malpractice in paediatrics. Rev Med Microbiol 2000; 11 : 189-95.

8. Opal SM, Mayer KH, Medecros AA. Mechanisms of Bacterial Resistance. In: Mandell GL, Bennetl JE, Dolin R, editors. Principles and practice of infectious diseases. 5th ed.Vol.II. New York, USA: Churchill Livingstone; 2000 p. 236-53.

9. Rice LB, Bonomo RA. Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents. In: Lorian V, editor. Antibiotics in laboratory medicine. 4th ed. Baltimore, USA:Willims & Wilkins; 1996 p. 453-501.

10. Day M. Bacteriocins and bacteriophages. In: Collier L, Balows A, SussmanM, editors. Topley & Wilson’s microbiology and microbial infections. 9th ed. Vol.2. London: Arnold; 1998 p. 185-93.

11. Tenover FC. Novel and emerging mechanisms of antimicrobial resistance in nosocomial pathogens. Am J Med 1991; 91 : 76S-81S.

12. Rubens CE, McNeill WF, Farrar WE Jr. Evolution of multiple antibiotic resistance plasmids mediated by transposable plasmid deoxyribonucleic acid sequences. J Bacteriol 1979; 140 : 713-9.

13. Bennett PM, Howe TGB. Bacterial and bacteriophage genetics. In: Collier L, Balows A, Sussman M, editors. Topley & Wilson’s microbiology and microbial infections 9th ed. Vol.2. London: Arnold; 1998 p. 231-94.

14. Chambeis H.F. Penicillin. In: Mandell GL, Bennetl JE, Dolin R, editors. Principles and practice of infectious diseases. 5th ed. Vol.1. New York, USA: Churchill Livingstone; 2000 p. 261-74.

15. Mulligan ME, Murray-Leisure KA, Ribner BS,Standiford HC, John JF, Korvick JA, et al.Methicillin-resistant Staphylococcus aureus : A consensus review of the microbiology, pathogenesis and epidemiology with implications for prevention and management. Am J Med 1993; 94 : 313-28.

16. Garau J, Wilson W, Wood M, Carlet J. Fourth generation cephalosporins : A review of in vitro activity, pharmacokinetics, pharmaco-dynamics and clinical utility. Clin Micro Infect 1997; 3 (Suppl 1): S87-101.

17. Livermore, DM, Acquired carbapenemases. J Antimicrob Chemother 1997; 39 : 673-6.

18. Kapil A. Antibiotics in gram negative sepsis. Trop Gastroenterol 2000; 21 : 95-102.

19. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin - resistant enterococci. Lancet 1988; i : 57-8.

20. Kunin CM, Tupasi T, Craig WA. Use of antibiotics. A brief exposition of the problem and some tentative solutions. Ann Intern Med 1973; 79 : 550-60.

21. Kapil A. Hospital acquired infections. Trop Gastroenterol 1998; 19 : 127-9.

22. Kaplan JM, Goretski SA, Keith S, Calford L. Cost of antibiotic therapy for infants and children. Pediatr Infect Dis J 1990; 9 : 722-8.

23. Gustafson RH, Bowen RE. Antibiotic use in animal agriculture. J Appl Microbiol 1997; 83 : 531-41.

24. Willis C, Booth H, Westacott S, Hawtin P. Detection of antibacterial agents in warm water prawns. Commun Dis Public Health 1999; 2 : 210-4.

25. Willis C. Antibiotics in the food chain : their impact on the consumer. Rev Med Microbiol 2000; 11 : 153-60.

26. Levy SB. Antibacterial household products: cause for concern. Emerg Infect Dis 2001; 7 (Suppl 3) : 512-5.

27. Kapil A, Ayyagari A, Garg RK, Agarwal KC. S. typhi with transferable chloramphenicol resistance isolated in Chandigarh during 1983-87. Indian J Pathol Microbiol 1994; 37 : 179-83.

28. Kumar R, Aneja KR, Punia AK, Roy P, Sharma M, Gupta R, et al. Changing Pattern of biolypes, Phage types and drug resistance of Salmonella typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113 : 175-80.

29. Chande C, Shrikhande S, Kapale S, Agrawal S, Fule R.P. Change in antimicrobial resistance pattern of Salmonella typhi in central India. Indian J Med Res 2002; 115 : 248-50.

30 Sood S, Kapil A , Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol sensitive Salmonella typhi. Lancet 1999; 353 : 1241-2.

31 Kapil A, Renuka K, Das B. Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi. Indian J Med Res 2002; 115 : 49-54.

32 Kapil A, Sood S, Dash NR, Das BK, Seth P. Ciprofloxacin in typhoid fever. Lancet 1999; 354 : 164.

33. Renuka K, Kapil A, Kabra SK, Wig N,Das BK, Prasad VV, et al. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of salmonella enterica serotype Typhi and serotype Paratyphi A. Microbial Drug Resistance 2004 ; 10 : 146-53.

34. Thirunarayanan MA, Jesudason MV, John TJ. Resistance of Shigella to nalidixic acid & fluorinated quinolones. Indian J Med Res 1993; 97 : 239-41.

35. Jesudason MV. Shigella isolation in Vellore, south India (1997-2001). Indian J Med Res 2002 ; 115 : 11-3.

36. Dutta S, Dutta S, Dutta P, Matsushita S, Bhattacharya SK, Yoshida S. Shigella dysenteriae serotype 1, Kolkata, India. Emerg Infect Dis 2003; 9 : 1471-4.

37. Jesudason MV, Saaya R. Resistance of Vibrio cholerae 01 to nalidixic acid. Indian J Med Res 1997; 105 : 153-7.

38. Ramamurthy T, Rajendran K, Garg P, Shimada T, Basu A, Chowdhury NR, et al. Cluster analysis & patterns of dissemination of multidrug resistance among clinical strains of Vibrio cholerae in Calcutta, India. Indian J Med Res 2000; 112 : 78-85.

39. Mohanty S, Kapil A, Das B.K. Seasonality and Antimicrobial resistance pattern of Vibrio cholerae in a tertiary care hospital of north India. Trop Doct 2004; 34 : 249-51.

40. Dhawan B, Mohanty S, Das BK, Kapil A. Antimicrobial susceptibility patterns of staphylococci in a tertiary care hospital. Natl Med J India 2004; 17 : 52-3.

41. Mohanty S, Kapil A, Dhawan B, Das BK. Bacteriological and antimicrobial susceptibility profile of soft tissue infections from northern India. Indian J Med Sci 2004; 58 : 10-5.

42. Kluytmans J, Van Belkum A, Verbrugher H. Nasal carriage of Staphylococcus aureus. Epidemiology, underlying mechanisms and associated risks. Clin Microbiol Rev 1997; 10 : 505-20.

43. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40 : 135-6.

44. Eliopoulous GM, Moellering RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in laboratory medicine. 4th ed. Baltimore, USA: Willims & Wilkins; 1996 p. 813-34.

45. Mohanty S, Kapil A, Das BK, Dhawan B. Antimicrobial resistance profile of nosocomial uropathogens in a tertiary care hospital. Indian J Med Sci 2003; 57 : 148-54.

46. Mathur P, Kapil A, Chandra R, Sharma P, Das B. Antimicrobial resistance in Enterococcus faecalis in a tertiary care centre of northern India. Indian J Med Res 2003; 118 : 25-8.

47. Mathur P, Kapil A, Das B , Dhawan B, Dwivedi SN. Invasive b-haemolytic streptococcal infections in a tertiary care hospital in northern India. J Med Microbiol 2002; 51 : 791-2.

48. Mathur P, Kapil A, Das B, Dhawan B, Dwivedi SN. Spectrum of beta-haemolytic streptococcal soft tissue infections at a tertiary care hospital of north India. Indian J Med Res 2003; 118 : 187-91.

49. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997; 24 (Suppl) : S85-8.

50. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN), Lancet 1999; 10: 353 : 1216-21.

51. Lalitha MK, Pai R, Manoharan A, Appelbaum PC, CMCH Pneumococcal Study Group. Multidrug resistant Streptococcus pneumoniae from India. Lancet 2002; 359 (9304) : 445.

52. Nag VL, Ayyagari A, Venkatesh V, Ghar M, Yadav V, Prasad KN. Drug resistant Haemophilus influenzae from respiratory tract infection in a tertiary care hospital in north India. Indian J Chest Dis Allied Sci 2001; 43 : 13-7.

53. Invasive Bacterial Infections Surveillance (IBIS) Group of the International Clinical Epidemiology Network. Are Haemophilus influenzae infections a significant problems in India? A prospective study and review. Clin Infect Dis 2002; 34 : 949-57.

54. Mandal P, Kapil A, Goswami K, Das B, Dwivedi SN. Uropathogenic Escherichia coli causing urinary tract infections Indian J Med Res 2001; 114 : 207-11.

55. Agarwal G, Kapil A, Kabra SK, Chandra R, Das B, Diwedi SN. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India. Indian J Med Res 2002; 116 : 73-81.

56. Pandey A, Kapil A, Sood S, Goel V, Das B, Seth P. In vitro activity and Amoxicillin-clavulanic acid and Ampicillin Sulbactum against Acinetobacter baumannii. J Clin Microbiol 1998; 36 : 3415-6.

57. Kapil A, Bali R, Das BK. In vitro susceptibility of nosocomial isolates against - a new aminoglycoside Isepamicin. Indian J Med Res 2001; 113 : 60-2.

58. Suri A, Mahapatra AK, Kapil A. Acinetobacter infections in neurosurgical intensive care patients. Nat Med J India 2000; 13 : 296-300.

59. Garg PK, Khanna S, Bohidar NP, Kapil A, Tandon RK. Incidence, spectrum and antibiotic sensitivity pattern of bacterial infections among patients with acute pancreatitis. J Gastroenterol Hepatol 2001; 16 : 1055-9.

60. Dhawan B, Bonnet R, Shukla NK, Mathur P, Das BK, Kapil A. Infection with extended spectrum b-lactamase producing strain of Serratia marcescens following tongue reconstruction. J Clin Microbiol 2003; 41 : 2233-4.

61. Dhawan B, Das BK, Mathur P, Kapil A. Bacteriological profile of post-neurosurgical meningitis in Indian children. Trop Doct 2004; 34 : 58-9.

62. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum b- lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002; 115 : 153-7.

63. Mathai D, Rhomberg PR, Biedenbach DJ, Jones RN. Indian Antimicrobial Resistance Study Group. Evaluation of the in vitro activity of six broad spectrum b-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagnostic Microbiol Infect Dis 2002; 44 : 367-77.

64. Bonhoeffer S, Lipsitch M, Levin BR. Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 1997; 94 : 12106-11.

65. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporins resistance in nosocomial Klebsiella. JAMA 1998; 280 : 1233-7.

66. Scheld W.M. Maintaining fluoroquinolone class efficacy: Review of influencing factors. Emerg Infect Dis 2003; 9 : 1-9.

67. John JF. In: Antibiotic cycling: is it ready for prime time? Infect Control Hosp Epidemiol 2000; 21 : 9-11.


rating: 3.82 from 17 votes | updated on: 27 Aug 2007 | views: 35871 |

Rate article:







excellent!bad…